{"entity":{"type":"insider","cik":"0001589597","url":"/insider/0001589597","json_url":"/insider/0001589597.json","name":"WILSON TROY EDWARD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":20,"first":"2020-06-15","last":"2026-08-24","span_basis":"filed_date"},"name_variants":[{"name":"WILSON TROY EDWARD","source":"filing","n_filings":20,"first_seen":"2020-06-15","last_seen":"2026-08-24"}],"transactions":[{"id":9300573,"accession":"0001193125-26-363812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-363812","line_url":"/filing/0001193125-26-363812#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":12.39,"price_display":"12.39","price_state":"stated","total_value":1239000.0,"total_display":"1,239,000.00","total_whole":"1,239,000","shares_owned_after":479194.0,"shares_owned_after_display":"479,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-24","filed_date":"2026-08-24","scope":"insider"},{"id":9255773,"accession":"0001193125-26-354201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-354201","line_url":"/filing/0001193125-26-354201#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":11.12,"price_display":"11.12","price_state":"stated","total_value":1112000.0,"total_display":"1,112,000.00","total_whole":"1,112,000","shares_owned_after":379194.0,"shares_owned_after_display":"379,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-17","scope":"insider"},{"id":6147836,"accession":"0001437749-26-020709","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-020709","line_url":"/filing/0001437749-26-020709#line-2","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10800.0,"shares_display":"10,800","price_per_share":7.1989,"price_display":"7.20","price_state":"stated","total_value":77748.12,"total_display":"77,748.12","total_whole":"77,748","shares_owned_after":59750.0,"shares_owned_after_display":"59,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-15","scope":"insider"},{"id":4754694,"accession":"0001193125-25-223663","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-223663","line_url":"/filing/0001193125-25-223663#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36615.0,"shares_display":"36,615","price_per_share":8.9422,"price_display":"8.94","price_state":"stated","total_value":327418.653,"total_display":"327,418.65","total_whole":"327,419","shares_owned_after":246853.0,"shares_owned_after_display":"246,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-09-29","scope":"insider"},{"id":4642165,"accession":"0001415889-25-023974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-023974","line_url":"/filing/0001415889-25-023974#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":8.2029,"price_display":"8.20","price_state":"stated","total_value":410145.0,"total_display":"410,145.00","total_whole":"410,145","shares_owned_after":100968.0,"shares_owned_after_display":"100,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-08","filed_date":"2025-09-09","scope":"insider"},{"id":4475035,"accession":"0001599901-25-000177","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001599901-25-000177","line_url":"/filing/0001599901-25-000177","is_derivative":false,"issuer_cik":"0001589597","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001589597","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29500.0,"shares_display":"29,500","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":1475000.0,"total_display":"1,475,000.00","total_whole":"1,475,000","shares_owned_after":54425.0,"shares_owned_after_display":"54,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-09","scope":"insider","n_lines":2},{"id":4619993,"accession":"0000950170-25-108844","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-108844","line_url":"/filing/0000950170-25-108844#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13494.0,"shares_display":"13,494","price_per_share":6.6417,"price_display":"6.64","price_state":"stated","total_value":89623.0998,"total_display":"89,623.10","total_whole":"89,623","shares_owned_after":50968.0,"shares_owned_after_display":"50,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-14","scope":"insider"},{"id":4619987,"accession":"0000950170-25-108844","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-108844","line_url":"/filing/0000950170-25-108844#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36506.0,"shares_display":"36,506","price_per_share":5.8505,"price_display":"5.85","price_state":"stated","total_value":213578.353,"total_display":"213,578.35","total_whole":"213,578","shares_owned_after":37474.0,"shares_owned_after_display":"37,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-14","scope":"insider"},{"id":4221969,"accession":"0001599901-25-000154","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001599901-25-000154","line_url":"/filing/0001599901-25-000154","is_derivative":false,"issuer_cik":"0001589597","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001589597","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95054.0,"shares_display":"95,054","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":4277430.0,"total_display":"4,277,430.00","total_whole":"4,277,430","shares_owned_after":69425.0,"shares_owned_after_display":"69,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-06","filed_date":"2025-08-08","scope":"insider","n_lines":6},{"id":4646831,"accession":"0001437749-25-020721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-020721","line_url":"/filing/0001437749-25-020721#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10800.0,"shares_display":"10,800","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":36720.0,"total_display":"36,720.00","total_whole":"36,720","shares_owned_after":43550.0,"shares_owned_after_display":"43,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-13","filed_date":"2025-06-17","scope":"insider"},{"id":2556529,"accession":"0001437749-24-020574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-020574","line_url":"/filing/0001437749-24-020574#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":3.3297,"price_display":"3.33","price_state":"stated","total_value":89901.9,"total_display":"89,901.90","total_whole":"89,902","shares_owned_after":350.0,"shares_owned_after_display":"350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-13","filed_date":"2024-06-17","scope":"insider"},{"id":2386281,"accession":"0000950170-24-008020","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-008020","line_url":"/filing/0000950170-24-008020","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91052.0,"shares_display":"91,052","price_per_share":20.23,"price_display":"20.23","price_state":"stated","total_value":1841981.96,"total_display":"1,841,981.96","total_whole":"1,841,982","shares_owned_after":559.0,"shares_owned_after_display":"559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-26","scope":"insider","n_lines":2},{"id":8167783,"accession":"0001437749-23-017612","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-23-017612","line_url":"/filing/0001437749-23-017612#line-2","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":3.4544,"price_display":"3.45","price_state":"stated","total_value":93268.8,"total_display":"93,268.80","total_whole":"93,269","shares_owned_after":350.0,"shares_owned_after_display":"350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider"},{"id":6513438,"accession":"0001437749-22-015529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-015529","line_url":"/filing/0001437749-22-015529#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27858.0,"shares_display":"27,858","price_per_share":2.5835,"price_display":"2.58","price_state":"stated","total_value":71971.143,"total_display":"71,971.14","total_whole":"71,971","shares_owned_after":27350.0,"shares_owned_after_display":"27,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-16","filed_date":"2022-06-21","scope":"insider"},{"id":4621967,"accession":"0001209191-21-040041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-040041","line_url":"/filing/0001209191-21-040041#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25748.0,"shares_display":"25,748","price_per_share":11.3575,"price_display":"11.36","price_state":"stated","total_value":292432.91,"total_display":"292,432.91","total_whole":"292,433","shares_owned_after":350.0,"shares_owned_after_display":"350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-11","scope":"insider"},{"id":2083841,"accession":"0001209191-20-054328","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-054328","line_url":"/filing/0001209191-20-054328","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":157106.0,"shares_display":"157,106","price_per_share":34.0,"price_display":"34.00","price_state":"stated","total_value":5341604.0,"total_display":"5,341,604.00","total_whole":"5,341,604","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-08","filed_date":"2020-10-08","scope":"insider","n_lines":2},{"id":2083833,"accession":"0001209191-20-054328","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-054328","line_url":"/filing/0001209191-20-054328","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104486.0,"shares_display":"104,486","price_per_share":32.08778209520893,"price_display":"32.09","price_state":"stated","total_value":3352724.0,"total_display":"3,352,724.00","total_whole":"3,352,724","shares_owned_after":106736.0,"shares_owned_after_display":"106,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-07","filed_date":"2020-10-08","scope":"insider","n_lines":2},{"id":2083817,"accession":"0001209191-20-054328","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-054328","line_url":"/filing/0001209191-20-054328#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":3200.0,"total_display":"3,200.00","total_whole":"3,200","shares_owned_after":206636.0,"shares_owned_after_display":"206,636","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-06","filed_date":"2020-10-08","scope":"insider"},{"id":2557836,"accession":"0001209191-20-050590","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-050590","line_url":"/filing/0001209191-20-050590#line-4","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98490.0,"shares_display":"98,490","price_per_share":28.824,"price_display":"28.82","price_state":"stated","total_value":2838875.76,"total_display":"2,838,875.76","total_whole":"2,838,876","shares_owned_after":206736.0,"shares_owned_after_display":"206,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-15","scope":"insider"},{"id":2557831,"accession":"0001209191-20-050590","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-050590","line_url":"/filing/0001209191-20-050590","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18411.0,"shares_display":"18,411","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":515508.0,"total_display":"515,508.00","total_whole":"515,508","shares_owned_after":28096.0,"shares_owned_after_display":"28,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-11","filed_date":"2020-09-15","scope":"insider","n_lines":2},{"id":3091127,"accession":"0001209191-20-050028","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-050028","line_url":"/filing/0001209191-20-050028","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38055.0,"shares_display":"38,055","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":1065540.0,"total_display":"1,065,540.00","total_whole":"1,065,540","shares_owned_after":28096.0,"shares_owned_after_display":"28,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-10","filed_date":"2020-09-10","scope":"insider","n_lines":2},{"id":3091112,"accession":"0001209191-20-050028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-050028","line_url":"/filing/0001209191-20-050028#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":1300000.0,"total_display":"1,300,000.00","total_whole":"1,300,000","shares_owned_after":306736.0,"shares_owned_after_display":"306,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":2557456,"accession":"0001209191-20-048438","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-048438","line_url":"/filing/0001209191-20-048438#line-5","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23053.0,"shares_display":"23,053","price_per_share":22.374,"price_display":"22.37","price_state":"stated","total_value":515787.822,"total_display":"515,787.82","total_whole":"515,788","shares_owned_after":28096.0,"shares_owned_after_display":"28,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-25","filed_date":"2020-08-26","scope":"insider"},{"id":2557442,"accession":"0001209191-20-048438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-048438","line_url":"/filing/0001209191-20-048438#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6568.0,"shares_display":"6,568","price_per_share":22.0417,"price_display":"22.04","price_state":"stated","total_value":144769.8856,"total_display":"144,769.89","total_whole":"144,770","shares_owned_after":28096.0,"shares_owned_after_display":"28,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-24","filed_date":"2020-08-26","scope":"insider"},{"id":2472023,"accession":"0001209191-20-047616","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-20-047616","line_url":"/filing/0001209191-20-047616#line-9","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11913.0,"shares_display":"11,913","price_per_share":22.0932,"price_display":"22.09","price_state":"stated","total_value":263196.2916,"total_display":"263,196.29","total_whole":"263,196","shares_owned_after":28096.0,"shares_owned_after_display":"28,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-19","filed_date":"2020-08-19","scope":"insider"},{"id":2472016,"accession":"0001209191-20-047616","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-047616","line_url":"/filing/0001209191-20-047616#line-7","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":521.0,"shares_display":"521","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":11462.0,"total_display":"11,462.00","total_whole":"11,462","shares_owned_after":28096.0,"shares_owned_after_display":"28,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-19","scope":"insider"},{"id":2472008,"accession":"0001209191-20-047616","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-047616","line_url":"/filing/0001209191-20-047616","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62901.0,"shares_display":"62,901","price_per_share":22.00073836028044,"price_display":"22.00","price_state":"stated","total_value":1383868.4436,"total_display":"1,383,868.44","total_whole":"1,383,868","shares_owned_after":356736.0,"shares_owned_after_display":"356,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider","n_lines":2},{"id":2470717,"accession":"0001209191-20-036624","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-036624","line_url":"/filing/0001209191-20-036624#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001589597","owner_name":"WILSON TROY EDWARD","owner_display_name":"WILSON TROY EDWARD","owner_url":"/insider/0001589597","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25245.0,"shares_display":"25,245","price_per_share":9.97,"price_display":"9.97","price_state":"stated","total_value":251692.65,"total_display":"251,692.65","total_whole":"251,693","shares_owned_after":26098.0,"shares_owned_after_display":"26,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":35,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001422143","name":"Kura Oncology, Inc.","url":"/issuer/0001422143","role":"Director, Officer (President and CEO)","n_filings":11,"first_seen":"2020-08-19","last_seen":"2026-08-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001401667","name":"PUMA BIOTECHNOLOGY, INC.","url":"/issuer/0001401667","role":"Director","n_filings":7,"first_seen":"2020-06-15","last_seen":"2026-06-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001599901","name":"Avidity Biosciences, Inc.","url":"/issuer/0001599901","role":"Director","n_filings":2,"first_seen":"2025-08-08","last_seen":"2025-09-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001589597","retrieved_at":"2026-08-25T19:14:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}